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Parainfectious Optic Neuritis: Manifestations in
Children vs Adults
Daniel Rappoport, MD, Nitza Goldenberg-Cohen, MD, Judith Luckman, MD,
Hana Leiba, MD
Background: Parainfectious optic neuritis may appear at
any age. The aim of our report was to compare the clinical
manifestations and outcomes of this form of optic neuritis
between children and adults.
Methods: The study sample consisted of all patients
diagnosed with parainfectious optic neuritis evaluated by
2 neuro-ophthalmology services between 2005 and 2012.
Data were collected retrospectively from the medical ﬁles.
Findings were compared between patients aged 0–18 years
and 19 years or older.
Results: Ten children (50% female) and 8 adults (50%
female) met the study criteria. Mean duration of follow-up
was 29.4 months (range, 2–72 months) in the pediatric
group and 14.2 months (range, 5–80 months) in the adult
group. Respective rates of bilateral disease were 50% and
38%, and all patients had optic disc swelling. The associ-
ated pathogen was identiﬁed in 60% of the pediatric group,
mainly Mycoplasma pneumoniae, and 75% of the adult
group, in which no microorganism predominated. The
interval from the febrile illness to symptom onset was 6
days (range, 1–14 days) in the pediatric group and 19.5
days (range, 14–30 days) in the adult group. Acute dis-
seminated encephalomyelitis (ADEM) was diagnosed in
40% (4/10) of the children and none of the adults. Final
visual outcome was 20/30 or better in all patients. There
was a higher frequency of bilateral disease in prepubescent
vs postpubescent children.
Conclusions: Parainfectious optic neuritis is associated
with a favorable visual prognosis regardless of age. Children
tend to manifest visual symptoms sooner after the ante-
cedent infectious illness and more often bilaterally and in
conjunction with ADEM. The causative agent is isolated less
frequently in children compared with adults.
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O ptic neuritis is a major cause of visual impairment andmay be due to demyelinating inﬂammatory and infec-
tious etiologies (1–7). Optic neuritis associated with an
infectious etiology may be due to direction invasion by
the pathogen or after an infectious disease, presumably on
an autoimmune basis (1). This latter setting is designated
parainfectious optic neuritis.
Optic neuritis may occur at any age. The annual incidence
is lower in children (0.33–1.66 per 1,000,000) than in adults
(5.1 per 1,000,000) (1). The presentation also differs by age
group: children more often have bilateral disease, frequently
with optic disc edema (5–9). In children, after a visual illness,
optic neuritis has been reported to occur in up to 66% of
cases (9). Corresponding data in adults are lacking. The aim
of our study was to compare the clinical manifestations, path-
ogenic organisms, treatment, and outcome of parainfectious
optic neuritis between children and adults.
METHODS
A retrospective case series design was used. The databases of
tertiary pediatric (Schneider Children’s Medical Center)
and adult (Kaplan Medical Center) medical center neuro-
ophthalmology services were searched for all patients diag-
nosed with optic neuritis from January 2005 through
November 2012. The main criterion for inclusion was acute
onset of optic neuritis within 1 month after an infectious
disease. Only patients who underwent complete evaluation
including neuroimaging were included. The presence of an
infectious disease was deﬁned by the clinical history,
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laboratory ﬁndings of lymphocytosis or leukocytosis, posi-
tive serological testing in blood or cerebrospinal ﬂuid (CSF),
and positive blood or CSF culture when performed. The
diagnosis of optic neuritis was based on a ﬁnding of at least
one manifestation of optic nerve disease: reduced visual
acuity, abnormal color vision, relative afferent pupillary
defect, or visual ﬁeld defect with or without optic disc
edema in one or both eyes. Exclusion criteria were optic
neuropathy from causes other than infection, a space-
occupying lesion on brain imaging, idiopathic intracranial
hypertension, and absence of evidence of infection.
The medical ﬁles and neuroimaging studies of the
eligible patients were reviewed, and demographic, clinical,
treatment, and outcome data were recorded. Findings were
compared between patients aged 0–18 years and 19 years or
older, and between prepubescent and postpubescent chil-
dren, alone or combined with the adult group. The study
was approved by the institutional review boards of both
medical centers.
RESULTS
Twenty-four patients met the inclusion criteria, of whom 6
were later excluded because of missing hospital or follow-up
data. The demographic data of the patients are shown in
Tables 1 and 2. There were 10 children aged 7–16 years
(mean, 12.7 years), of whom 4 were prepubescent, and 8
adults aged 19–45 years (mean, 31 years). The mean dura-
tion of follow-up was 29.4 months (range, 5–72 months) in
the pediatric group and 14.2 months (range, 5–40 months)
in the adult group.
The ophthalmologic ﬁndings are shown in Tables 3 and
4. Initial visual acuity was documented in 7 children, of
whom 5 (71%) had acuity of 20/150 or worse, and 7 adults,
of whom 6 (86%) had visual acuity of 20/40 or better. All
patients had either unilateral or bilateral optic disc edema.
One adult (patient 3) had a partial macular star. Systemic
neurological manifestations (headache, meningitis, enceph-
alitis) occurred in 6 children. On magnetic resonance imag-
ing (MRI), 4 children (40%) had ﬁndings consistent with
acute disseminated encephalomyelitis (ADEM) and 1 child
(10%) had nonspeciﬁc white matter lesions without clinical
encephalitis. In the adult group, 2 patients (25%) had non-
speciﬁc white matter lesions and 1 (12%) had lesions con-
sistent with microangiopathic changes. None of the adults
had ADEM.
Lumbar puncture demonstrated normal opening pressure
in all patients. Protein and glucose levels were within normal
limits in all the patients, except 2 children with meningitis,
although no pathogen was identiﬁed in their CSF.
An infectious pathogen was identiﬁed by serology or
culture in 6 children (60%) and 6 adults (75%) (Table 5).
The main pathogen in the children’s group was Mycoplasma
pneumoniae, found in 4 of 6 patients (67%). In the adult
group, there was no common pathogen.
Four children were prepubescent. Comparison of this
subgroup with the postpubescent children alone (6/10) or
combined with the adults (total 14 patients) yielded no
differences in any of the parameters except for a higher rate
of bilateral optic neuritis disease in the prepubescent
subgroup (3/4, 75%).
Corticosteroid treatment was administered to 7 children
and 4 adults (Tables 1 and 2). All treated children received
intravenous methylprednisolone (10 mg/kg/day) for at least 3
days. Adults received either oral prednisone (2 mg/kg/day)
for 2 weeks or intravenous methylprednisolone (1 g/d) for 3
days followed by oral prednisone 60 mg/d for an additional
11 days. Final visual outcome was 20/30 or better in all
patients. There was no correlation between ﬁnal visual out-
come and whether or not steroid treatment was given. There
were no instances of recurrent optic neuritis during the
follow-up period.
DISCUSSION
In our study of parainfectious optic neuritis, the gender
distribution was equal in the adult group and almost equal in
the pediatric group. In most previous studies of optic
neuritis, a female predominance has been reported and in
children, the disease affected male and female patients equally
before puberty and female patients more often after puberty
(1,7–9). However, in these reports, cases of parainfectious
optic neuritis were included in larger patient cohort studies.
In our case series, initial visual acuity tended to be worse
in children but both groups had equally good visual
outcomes. These results are in agreement with previous
studies (1,7,10). Nevertheless, the visual ﬁeld defects were
milder than expected, perhaps owing to the early diagnosis
due to the acute febrile disease and early and aggressive
treatment (antibiotics and steroids). Interestingly, all pa-
tients had swollen discs at presentation. This ﬁnding was
not mentioned in previous reports.
Our results highlight additional differences in clinical
characteristics of parainfectious optic neuritis between chil-
dren and adults. Time elapsed between the febrile illness and
the onset of the visual symptoms was shorter in the pediatric
group. This ﬁnding might be explained by a more fulminant
immune response in children, manifested by the presence of
bilateral optic nerve involvement and other neurological
symptoms, with or without MRI abnormalities, consistent
with ADEM. This may also be the reason why more children
than adults experienced bilateral optic nerve involvement.
This observation has been described in pediatric optic
neuritis regardless of etiology (8,10,11).
In the adult group, the diagnosis of optic neuritis days to
weeks after the presumed systemic infection support the
theory that parainfectious optic neuritis is due to an
immunologic–inﬂammatory reaction (1,5–11). The rare
occurrence of uveitis in these cases also may be related to
this reaction.
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TABLE 1. Clinical data of children with parainfectious optic neuritis
Patient
No.
Age,
yr Gender
Follow-
up, mo
Side of
ON
Preceding Infection/
Pathogen
Time From
Infection to
ON (days)
MRI/CT Findings at
Diagnosis
MRI/CT Findings at
the End of Follow-up Treatment
1 14 F 72 Bilateral Viral meningitis (no
pathogen found)
5 Lesions in thalamus:
ADEM; optic nerve
enhancement
None Steroids IV
2* 11 F 8 Bilateral M. pneumoniae,
febrile illness
14 2 nonspeciﬁc
periventricular
lesions
Not done Steroids IV
3 14 M 40 LE Pansinusitis 1 MRI: no lesions Not done Steroids IV + oral
amoxicillin
4 13 F 7 RE Sinusitis; EBV IgM 5 MRI: diffuse white
matter lesions,
ADEM
None Steroids IV
5* 7 M 9 LE Meningoencephalitis (no
pathogen found)
10 MRI: multiple white
matter lesions,
ADEM
Some lesions
disappeared or
became smaller
Steroids IV + oral
cefuroxime +
doxycycline +
acyclovir IV
6 16 F 12 Bilateral Pneumonia, M. pneumoniae 5 MRI: multiple brain
lesions, ADEM;
optic nerve
enhancement
None Steroids IV + oral
roxithromycin
7 14 M 18 RE Nonspeciﬁc viral illness:
brother had chicken pox
(varicella) 7–10 days
before (no pathogen
found)
Unknown No brain lesions; optic
nerve enhancement
Not done Steroids IV
8* 12 M 72 Bilateral Nonspeciﬁc headaches,
throat culture positive for
Streptococcus. pyogenes
Unknown No brain lesions Not done Oral penicillin
9 13.5 M 16 RE Headaches, gastroenteritis;
M. pneumoniae, IgM
5 No brain lesions Not done None
10* 12.5 F 40 RE M. pneumonia, IgM; no
febrile illness
Unknown No brain lesions Not done Oral azithromycin
*Prepubescent children.
ADEM, acute disseminated encephalomyelitis; CT, computed tomography; EBV, Epstein–Barr virus; F, female; LE, left eye; M, male; MRI, magnetic resonance imaging; ON, optic neuritis;
RE, right eye.
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TABLE 2. Clinical data of adults with parainfectious optic neuritis
Patient
No.
Age,
yr Gender
Follow-up
(months)
Side of
ON
Preceding
Infection/
Pathogen
Time From
Infection to
ON (days) MRI/CT Findings at Diagnosis
MRI/CT
Findings at
End of Follow-
up Treatment
1 27 M 6 Bilateral Febrile illness,
CMV IgM
28 Enlarged lateral ventricles None Vitamin B12 (because
of deﬁciency)
2 23 F 5 LE Gastroenteritis,
CMV IgM
21 No abnormalities Not done Steroids IV and then
oral
3 24 M 7.5 RE Headache,
Coxiella
burnetii/Q
fever, IgM
14 One nonspeciﬁc white
matter lesion
Not done Oral doxycycline
4 19 F 5 Bilateral Nonspeciﬁc
febrile illness
(no pathogen
found)
14 Optic nerve thickening, no
enhancement, no brain lesions
Not done Oral steroids
5 34 M 6 LE Nonspeciﬁc
febrile illness
(no pathogen
found)
28 Nonspeciﬁc white matter lesions Not done None
6 45 M 30 RE Uveitis: posterior;
HBV: HBcAg,
HBeAb
At same
time of
uveitis
White matter lesions:
periventricular and
supraventricular
(microangiopathic changes)
Not done Oral steroids +
lamivudine + steroid
eye drops
7 32 F 40 RE Fever,
Toxoplasma
IgM
28 No abnormalities Not done Oral clindamycin +
pyrimethamine +
sulfadiazine +
leucovorin
CMV, cytomegalovirus; F, female; HBcAg, hepatitis B core antigen; HBcAb, hepatits B E antibody; HBV, hepatitis B virus; LE, left eye; M, male; ON, optic neuritis; RE, right eye.
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TABLE 3. Ophthalmologic ﬁndings in children with parainfectious optic neuritis
Patient
No.
At Onset
Optic Disc
Edema
Visual Acuity
Dyschromatopsia RAPD VFRE LE
1 Bilateral NA NA NA NA NA
2 Bilateral 20/150 20/50 Bilateral RE Binasal constriction
3 LE 20/20 FC NA LE LE superior ﬁeld defect
4 RE NA =
diminished
NA NA NA NA
5 LE NA NA =
diminished
NA LE NA
6 Bilateral LP 20/480 Bilateral severe RE RE: central scotoma + superonasal constriction; LE: inferonasal
constriction
7 RE HM 20/22 Bilateral RE Bilateral nasal step
8 Bilateral 20/30 20/30 NA No Bilateral enlarged blind spot
9 RE 20/20 20/20 No NA RE: cecocentral scotoma
10 RE FC 20/20 NA RE RE: enlarged blind spot
Patient No.
At end of Follow-up
Optic Disc
Visual Acuity
Dyschromatopsia RAPD VFRE LE
1 Bilateral temporal pallor 20/20 20/25 No No Generalized depression
2 Normal 20/25 20/20 No RE mild Normal
3 Normal 20/20 20/20 No No Normal
4 Normal 20/20 20/20 No No Normal
5 LE: mild pallor 20/20 20/30 No No Normal
6 Bilateral temporal pallor 20/20 20/20 No No Bilateral mild nasal constriction
7 Normal 20/25 20/22 No RE: mild RE constriction
8 Normal 20/20 20/20 No No Normal
9 RE: mild pallor; LE: drusen 20/20 20/20 No No RE: mild cecocentral scotoma
10 Normal 20/20 20/20 No RE: trace Normal
FC, ﬁnger counting; HM, hand motion; LE, left eye; LP, light perception; NA, not available/not checked at onset due to peer condition; RAPD, relative afferent pupillary defect; RE, right eye; VF,
visual ﬁelds.
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TABLE 4. Ophthalmologic ﬁndings in adults with parainfectious optic neuritis
Patient No.
At Onset
Optic Disc Edema
BCVA
Dyschromatopsia RAPD VFRE LE
1 Bilateral 20/40 20/25 No No Normal
2 LE 20/20 20/30 LE LE LE: concentric constriction
3 RE 20/20 20/20 RE RE RE: enlarged blind spot
4 Bilateral 20/200 20/60 Bilateral RE Bilateral inferior deﬁcit
5 LE 20/40 20/40 Bilateral LE LE: enlarged blind spot
6 RE 20/40 20/20 RE RE RE: enlarged blind spot + inferior arcuate scotoma
7 RE 20/40 20/20 RE RE RE: enlarged blind spot
Patient No.
At End of Follow-up
Optic disc
BCVA
Dyschromatopsia RAPD VFRE LE
1 RE mild elevation 20/25 20/20 No No Normal
2 Normal 20/20 20/20 No No LE: generalized depression
3 Normal 20/20 20/20 No No Normal
4 Normal 20/20 20/20 No RE RE: enlarged blind spot
5 Normal 20/15 20/15 No No Bilateral inferior ﬁeld loss
6 RE: disc pallor 20/30 20/20 No No RE: generalized depression
7 Normal 20/20 20/20 No No Normal
BCVA, best corrected visual acuity; LE, left eye; NA, not available/not checked due to general deteriorated condition; RAPD, relative afferent pupillary defect; RE, right eye; VF, visual ﬁelds.
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We were able to identify an infectious pathogen in 6
children (55%) and 6 adults (75%). The majority of the culture
studies in the pediatric group (67%) grew M. pneumoniae; 2 of
these cases were associated with ADEM. Among the
adults with a positive culture, we did not ﬁnd a common
pathogen, which is consistent with the previous reports
(3,4,7,11,12).
Neurological complications of M. pneumoniae infection
in children include encephalitis and ADEM (12–21).
Mycoplasma also has been associated with optic neuritis
in children and adults (17–20). In our study, half of the
children infected with Mycoplasma had bilateral disease, an
observation described previously, especially in patients
with other neurological involvement such as encephalomy-
elitis (16–20).
One child in our study (Table 1, patient 4) had Epstein–
Barr virus–related sinusitis 5 days preceding the develop-
ment of unilateral optic neuritis and ADEM. Our search of
the literature yielded only one previous case report of a child
with bilateral parainfectious optic neuritis related to
Epstein–Barr virus infection (22). There are also reports
of 4 adults, 3 of whom had concomitant systemic neuro-
logical disease (23–26).
There is no consensus regarding treatment of parainfec-
tions optic neuritis (1–8,11). In our study, children were
given antibiotics and/or systemic corticosteroids more often
because they had concurrent systemic disease. However, treat-
ment was not associated with improved outcome in terms of
visual acuity, visual ﬁelds, or residual optic nerve damage.
In this case series, parainfectious optic neuritis presented
with optic disc swelling in 100% of the cases in both
children and adults. However, we found several differences
in the clinical presentation between these 2 age groups. The
disease in children tends to be diagnosed earlier, presents
more often bilaterally, and may be associated with ADEM.
Although the causative agent was isolated less frequently in
children, it tended to be consistent (usually M. pneumoniae).
Even in the presence of negative serology and blood and CSF
cultures, patients with a history and clinical presentation
suggesting a preceding infection should be treated appropri-
ately. In general, the visual prognosis is good.
We are aware of the limitations of our study. Our sample
size was small, particularly the prepubescent subgroup. We
attempted to exclude patients with multiple sclerosis, and
none developed clinical or neuroimaging evidence of
demyelinating disease. However, the follow-up period was
short and brain MRI was repeated in only 5 cases. Finally,
ours was a retrospective study that included potential
patient selection bias and nonstandardized approaches to
patient evaluation and treatment.
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